As prostate cancer progresses, it becomes increasingly aggressive and can metastasise. In this form, the tumor is difficult to treat, which is reflected in high mortality rates: Worldwide, the malignant disease of the prostate is the second most common cause of cancer death in men.
JUN protein could slow prostate cancer growth, study finds
- Post author:
- Post published:June 5, 2024
- Post category:uncategorized